Track the latest insights on oxytetracycline hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2026, the oxytetracycline hydrochloride prices in India reached 16.22 USD/KG in September. Prices eased as fermentation-based producers maintained steady operating rates while veterinary and pharmaceutical formulators limited purchases to immediate requirements. Softer export enquiries reduced the pace at which domestic output was absorbed. Sellers adjusted offers lower to keep material moving through the quarter.
During the third quarter of 2026, the oxytetracycline hydrochloride prices in Germany reached 14.54 USD/KG in September. Values declined as European formulators sourcing bulk active ingredient for veterinary medicine production bought only against confirmed orders. Comfortable availability from established supply channels limited the need for forward coverage. Distributors trimmed quotations to retain volume amid the quieter buying pace.
During the third quarter of 2026, the oxytetracycline hydrochloride prices in the United States reached 13.44 USD/KG in September. Prices moved lower as domestic animal health manufacturers paced intake to production schedules rather than building inventory. Adequate import availability from established origin markets kept the supply position comfortable. Suppliers conceded on price to sustain throughput through the closing weeks of the quarter.
During the third quarter of 2026, the oxytetracycline hydrochloride prices in China reached 12.23 USD/KG in September. Prices firmed as fermentation plant operating rates tightened and export demand from overseas veterinary formulators picked up through the quarter. Producers directed a larger share of output toward committed trade positions, leaving less material for open market sale. The firmer cost environment supported higher quotations issued by domestic suppliers.
During the third quarter of 2026, the oxytetracycline hydrochloride prices in Vietnam reached 12.95 USD/KG in September. Prices increased as import-dependent formulators faced firmer replacement costs on cargoes sourced from regional producers. Steady demand from veterinary feed premix and animal health manufacturers supported consistent offtake despite the higher cost base. Limited domestic production capacity kept the market reliant on imported material, reinforcing the impact of regional price movements on local offers.
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing oxytetracycline hydrochloride prices.
Q3 2026:
The oxytetracycline hydrochloride price index in Europe moved lower through the quarter, weighed by comfortable availability and restrained purchasing from downstream veterinary medicine producers. Germany, the region's principal consuming market, recorded softer quotations as formulators limited intake to confirmed production schedules rather than rebuilding stock. Established supply channels continued to deliver material without interruption, leaving sellers to compete for a thinning pool of orders. Buyers showed little urgency to commit ahead of requirements given the comfortable position across the supply chain. Distributors adjusted offer levels downward rather than hold material in store, reinforcing the easing direction. Demand from animal health and pharmaceutical formulation segments stayed steady but did not require additional volume beyond routine needs. The softer tone persisted through the closing weeks of the period.
This analysis can be extended to include detailed oxytetracycline hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
Q3 2026:
The oxytetracycline hydrochloride price index in North America trended downward during the quarter, shaped by ample import availability and cautious buying among downstream animal health manufacturers. The United States, the region's principal market, recorded softer quotations as formulators paced purchasing to confirmed production runs rather than forward cover. Adequate supply from established origin markets kept the overall position comfortable throughout the period. Buyers limited commitments to near-term requirements given the steady flow of incoming material. Suppliers conceded on price to sustain volume rather than carry excess stock. Veterinary pharmaceutical producers maintained consistent but measured offtake through the quarter. The market concluded the period with a softer undertone.
Specific oxytetracycline hydrochloride historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Q3 2026:
The study includes oxytetracycline hydrochloride price trends across the Middle East and Africa, taking into consideration variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.
In addition to region-wise data, information on oxytetracycline hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Q3 2026:
The oxytetracycline hydrochloride price index in Asia Pacific showed a mixed direction through the quarter, with firmer fermentation plant operating rates in China contrasting against easing conditions in India. China recorded higher quotations as producers tightened operating schedules and directed a larger share of output toward export commitments to overseas veterinary formulators. India saw softer values as domestic manufacturers maintained steady output while buyers confined purchases to immediate needs. Vietnam recorded firmer landed costs as import-dependent formulators faced higher replacement values from regional suppliers serving veterinary feed premix producers. Export competition among regional producers shaped the volumes available for open market purchase. Demand from animal health and pharmaceutical intermediate manufacturers remained the common thread supporting consumption across the region. The period closed with producers in the region holding firm on export-linked quotations.
This oxytetracycline hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Q3 2026:
The oxytetracycline hydrochloride market in Latin America is primarily shaped by regional import dependency and downstream industrial demand across veterinary pharmaceutical, animal feed premix, and human antibiotic formulation applications. However, due to logistics constraints and varying regulatory regimes, oxytetracycline hydrochloride prices might fluctuate dynamically across the region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
IMARC's latest publication, “Oxytetracycline Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the oxytetracycline hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of oxytetracycline hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed oxytetracycline hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting oxytetracycline hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

The global oxytetracycline hydrochloride market size reached USD 335.9 Million in 2025. By 2034, IMARC Group expects the market to reach USD 435.1 Million, at a projected CAGR of 2.83% during 2026-2034. Market growth is being driven by sustained demand for oxytetracycline hydrochloride in veterinary medicine and livestock health management, expanding use in animal feed premixes to support disease control in poultry and aquaculture, and continued application in human antibacterial formulations across emerging healthcare markets.
Oxytetracycline hydrochloride is the hydrochloride salt of oxytetracycline, a broad-spectrum antibiotic belonging to the tetracycline class of compounds, produced industrially as a bulk pharmaceutical active ingredient. Its molecular formula in Hill notation is C22H25ClN2O9, reflecting the parent tetracycline molecule combined with hydrochloric acid to improve its solubility and stability for formulation. The compound is typically a yellow crystalline powder, bitter in taste, soluble in water, and sensitive to light and prolonged heat exposure. It exhibits broad-spectrum bacteriostatic activity by inhibiting bacterial protein synthesis, a property that underpins its therapeutic function across human and veterinary medicine. Its principal industrial applications span veterinary pharmaceuticals, animal feed premix manufacturing, aquaculture health products, and human antibacterial drug formulation. End uses include its role as the active ingredient in injectable and oral veterinary antibiotic preparations, a medicated feed additive for livestock and poultry disease control, and a component in topical and systemic human antibiotic formulations. It is obtained by fermentation of the bacterium Streptomyces rimosus, followed by extraction, purification, and conversion of the resulting oxytetracycline base to its hydrochloride salt form.
| Key Attributes | Details |
|---|---|
| Product Name | Oxytetracycline Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Oxytetracycline Hydrochloride Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.